Get the Weekly Intelligence Brief — top committee picks every Sunday.

GMED vs TFX

Globus Medical vs Teleflex Incorporated — AI-powered side-by-side comparison
GMED
Globus Medical
71
Buy
VS
TFX
Teleflex Incorporated
49
Watch
MetricGMEDTFX
AI Score 71 49
Price $85.12 $133.43
P/E Ratio 21.45× -5.74×
ROE 11.8% -29.0%
Revenue Growth YoY
Gross Margin 68.5% 53.8%
Debt / Equity 0.02× 0.99×
Dividend Yield 0.0% 1.0%
RSI (14) 75.9 44.1
Beta 0.954 0.809
Expected Upside +0.1%

AI Committee View

Current Innellis committee reasoning for GMED versus TFX.
GMED leads by 22 points.

GMED scores 71/100 (Buy) versus TFX at 49/100 (Watch).

GMED Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
TFX Committee View
60% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -14.5% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • ROE of only -31.9% -- cheap may mean cheap for a reason — Value
  • Revenue declining -14.5% YoY -- this is not a growth story right now — Growth
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GMED Full Analysis TFX Full Analysis